{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:01:08Z","timestamp":1767913268225,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s41030-024-00254-2","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T13:02:21Z","timestamp":1709730141000},"page":"193-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Staphylococcus aureus Pneumonia in Can Tho, Vietnam: Clinical Characteristics, Antimicrobial Resistance Profile and Risk Factors of Mortality"],"prefix":"10.1007","volume":"10","author":[{"given":"Thu","family":"Vo-Pham-Minh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dang","family":"Tran-Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung","family":"Phan-Viet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thien","family":"Dinh-Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tran","family":"Nguyen-Thi-Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thuy","family":"Cao-Thi-My","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hien","family":"Nguyen-Thi-Dieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duong","family":"Vo-Thai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vu","family":"Nguyen-Thien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5926-9544","authenticated-orcid":false,"given":"Sy","family":"Duong-Quy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"issue":"10","key":"254_CR1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3390\/toxins13100677","volume":"13","author":"N Ahmad-Mansour","year":"2021","unstructured":"Ahmad-Mansour N, Loubet P, Pouget C, et al. Staphylococcus aureus toxins: an update on their pathogenic properties and potential treatments. Toxins (Basel). 2021;13(10):677.","journal-title":"Toxins (Basel)"},{"key":"254_CR2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/IDR.S97416","volume":"10","author":"AO Althaqafi","year":"2017","unstructured":"Althaqafi AO, Matar MJ, Moghnieh R, et al. Burden of methicillin-resistant Staphylococcus aureus pneumonia among hospitalized patients in Lebanon and Saudi Arabia. Infect Drug Resist. 2017;10:49\u201355.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"254_CR3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0761-8425(05)85612-8","volume":"22","author":"D Benhamou","year":"2005","unstructured":"Benhamou D, Carrie AS, Lecomte F. Staphylococcus aureus: role and impact in the treatment of nosocomial pneumonia. Rev Mal Respir. 2005;22(4):595\u2013603.","journal-title":"Rev Mal Respir"},{"issue":"10","key":"254_CR4","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1007\/s00134-003-1918-5","volume":"29","author":"V Boussaud","year":"2003","unstructured":"Boussaud V, Parrot A, Mayaud C, et al. Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus. Intensive Care Med. 2003;29(10):1840\u20133.","journal-title":"Intensive Care Med"},{"key":"254_CR5","doi-asserted-by":"publisher","DOI":"10.4081\/gc.2017.6377","author":"F Cacciatore","year":"2017","unstructured":"Cacciatore F, Gaudiosi C, Mazzella F, et al. Pneumonia and hospitalizations in the elderly. Geriatr Care. 2017. https:\/\/doi.org\/10.4081\/gc.2017.6377.","journal-title":"Geriatr Care"},{"key":"254_CR6","unstructured":"CDC. 2021. Pneumonia (Ventilator-associated pneumonia (VAP) and non-ventilator-associated pneumonia (PNEU)) Event, Device-associated Module. https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/6pscvapcurrent.pdf. Accessed 2 Mar 2021."},{"issue":"3","key":"254_CR7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1086\/589754","volume":"47","author":"PG Charles","year":"2008","unstructured":"Charles PG, Wolfe R, Whitby M, et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis. 2008;47(3):375\u201384.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"254_CR8","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jclinepi.2008.01.006","volume":"61","author":"ME Charlson","year":"2008","unstructured":"Charlson ME, Charlson RE, Peterson JC, et al. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61(12):1234\u201340.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"254_CR9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00134-011-2130-7","volume":"37","author":"EY Choi","year":"2011","unstructured":"Choi EY, Huh JW, Lim CM, et al. Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia. Intensive Care Med. 2011;37(4):639\u201347.","journal-title":"Intensive Care Med"},{"issue":"1","key":"254_CR10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jinf.2020.10.032","volume":"82","author":"C Cilloniz","year":"2021","unstructured":"Cilloniz C, Dominedo C, Gabarrus A, et al. Methicillin-susceptible Staphylococcus aureus in community-acquired pneumonia: risk factors and outcomes. J Infect. 2021;82(1):76\u201383.","journal-title":"J Infect"},{"issue":"4","key":"254_CR11","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/resp.12978","volume":"22","author":"C Cilloniz","year":"2017","unstructured":"Cilloniz C, Ewig S, Gabarrus A, et al. Seasonality of pathogens causing community-acquired pneumonia. Respirology. 2017;22(4):778\u201385.","journal-title":"Respirology"},{"issue":"11","key":"254_CR12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S1473-3099(17)30396-1","volume":"17","author":"GL Collaborators","year":"2017","unstructured":"Collaborators GL. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017;17(11):1133\u201361.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"254_CR13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10096-015-2566-8","volume":"35","author":"C De la Calle","year":"2016","unstructured":"De la Calle C, Morata L, Cobos-Trigueros N, et al. Staphylococcus aureus bacteremic pneumonia. Eur J Clin Microbiol Infect Dis. 2016;35(3):497\u2013502.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"254_CR14","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1164\/rccm.200602-177OC","volume":"174","author":"PP Espana","year":"2006","unstructured":"Espana PP, Capelastegui A, Gorordo I, et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med. 2006;174(11):1249\u201356.","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 3","key":"254_CR15","first-page":"iii19","volume":"66","author":"TM File Jr","year":"2011","unstructured":"File TM Jr, Low DE, Eckburg PB, et al. FOCUS 1: a randomized, double-blinded, multicentre, phase\u00a0III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. J Antimicrob Chemother. 2011;66(Suppl 3):iii19-32.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"254_CR16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","volume":"336","author":"MJ Fine","year":"1997","unstructured":"Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243\u201350.","journal-title":"N Engl J Med"},{"issue":"23","key":"254_CR17","first-page":"2526","volume":"307","author":"ADT Force","year":"2012","unstructured":"Force ADT, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526\u201333.","journal-title":"JAMA"},{"issue":"9308","key":"254_CR18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(02)07877-7","volume":"359","author":"Y Gillet","year":"2002","unstructured":"Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359(9308):753\u20139.","journal-title":"Lancet"},{"issue":"5","key":"254_CR19","doi-asserted-by":"crossref","first-page":"2004445","DOI":"10.1183\/13993003.04445-2020","volume":"58","author":"Y Gillet","year":"2021","unstructured":"Gillet Y, Tristan A, Rasigade JP, et al. Prognostic factors of severe community-acquired staphylococcal pneumonia in France. Eur Respir J. 2021;58(5):2004445.","journal-title":"Eur Respir J"},{"issue":"3","key":"254_CR20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1086\/519263","volume":"45","author":"Y Gillet","year":"2007","unstructured":"Gillet Y, Vanhems P, Lina G, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis. 2007;45(3):315\u201321.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"254_CR21","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3201\/eid1206.051141","volume":"12","author":"JC Hageman","year":"2006","unstructured":"Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003\u201304 influenza season. Emerg Infect Dis. 2006;12(6):894\u20139.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"254_CR22","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1378\/chest.09-2453","volume":"138","author":"NZ Haque","year":"2010","unstructured":"Haque NZ, Zuniga LC, Peyrani P, et al. Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia. Chest. 2010;138(6):1356\u201362.","journal-title":"Chest"},{"issue":"4","key":"254_CR23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0040-1709992","volume":"41","author":"H He","year":"2020","unstructured":"He H, Wunderink RG. Staphylococcus aureus pneumonia in the community. Semin Respir Crit Care Med. 2020;41(4):470\u20139.","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"254_CR24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015;373(5):415\u201327.","journal-title":"N Engl J Med"},{"key":"254_CR25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/1471-2334-13-370","volume":"13","author":"WJ Jung","year":"2013","unstructured":"Jung WJ, Kang YA, Park MS, et al. Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia. BMC Infect Dis. 2013;13:370.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"254_CR26","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61\u2013111.","journal-title":"Clin Infect Dis"},{"key":"254_CR27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/1471-2334-13-359","volume":"13","author":"N Khanafer","year":"2013","unstructured":"Khanafer N, Sicot N, Vanhems P, et al. Severe leukopenia in Staphylococcus aureus-necrotizing, community-acquired pneumonia: risk factors and impact on survival. BMC Infect Dis. 2013;13:359.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"254_CR28","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ajem.2008.07.037","volume":"27","author":"P Kontou","year":"2009","unstructured":"Kontou P, Kuti JL, Nicolau DP. Validation of the Infectious Diseases Society of America\/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae. Am J Emerg Med. 2009;27(8):968\u201374.","journal-title":"Am J Emerg Med"},{"issue":"5815","key":"254_CR29","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.1137165","volume":"315","author":"M Labandeira-Rey","year":"2007","unstructured":"Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science. 2007;315(5815):1130\u20133.","journal-title":"Science"},{"issue":"6","key":"254_CR30","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1159\/000319557","volume":"81","author":"HT Li","year":"2011","unstructured":"Li HT, Zhang TT, Huang J, et al. Factors associated with the outcome of life-threatening necrotizing pneumonia due to community-acquired Staphylococcus aureus in adult and adolescent patients. Respiration. 2011;81(6):448\u201360.","journal-title":"Respiration"},{"issue":"10","key":"254_CR31","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1586\/14787210.2013.827891","volume":"11","author":"B Loffler","year":"2013","unstructured":"Loffler B, Niemann S, Ehrhardt C, et al. Pathogenesis of Staphylococcus aureus necrotizing pneumonia: the role of PVL and an influenza coinfection. Expert Rev Anti Infect Ther. 2013;11(10):1041\u201351.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"Suppl 3","key":"254_CR32","doi-asserted-by":"crossref","first-page":"iii33","DOI":"10.1093\/jac\/dkr097","volume":"66","author":"DE Low","year":"2011","unstructured":"Low DE, File TM Jr, Eckburg PB, et al. FOCUS 2: a randomized, double-blinded, multicentre, phase\u00a0III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. J Antimicrob Chemother. 2011;66(Suppl 3):iii33-44.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"254_CR33","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1155\/2013\/585834","volume":"24","author":"DP Machado","year":"2013","unstructured":"Machado DP, Goldani LZ, Paiva RM, et al. The impact of serum vancomycin levels and minimum inhibitory concentrations of methicillin-resistant Staphylococcus aureus on mortality in patients with nosocomial pneumonia. Can J Infect Dis Med Microbiol. 2013;24(3):e75\u20139.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"7","key":"254_CR34","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45\u201367.","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 5","key":"254_CR35","doi-asserted-by":"crossref","first-page":"S378","DOI":"10.1086\/533594","volume":"46","author":"E Rubinstein","year":"2008","unstructured":"Rubinstein E, Kollef MH, Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46(Suppl 5):S378\u201385.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"254_CR36","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s10096-017-2970-3","volume":"36","author":"J Ruiz-Ramos","year":"2017","unstructured":"Ruiz-Ramos J, Vidal-Cortes P, Diaz-Lamas A, et al. Ventilator-associated pneumonia by methicillin-susceptible Staphylococcus aureus: do minimum inhibitory concentrations to vancomycin and daptomycin matter? Eur J Clin Microbiol Infect Dis. 2017;36(9):1569\u201375.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"254_CR37","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/cid\/ciw300","volume":"63","author":"WH Self","year":"2016","unstructured":"Self WH, Wunderink RG, Williams DJ, et al. Staphylococcus aureus community-acquired pneumonia: prevalence, clinical characteristics, and outcomes. Clin Infect Dis. 2016;63(3):300\u20139.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"254_CR38","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/cc4934","volume":"10","author":"AFCA Shorr","year":"2006","unstructured":"Shorr AFCA, Kollef MH, Chastre J, et al. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care. 2006;10(3):R97.","journal-title":"Crit Care"},{"issue":"9","key":"254_CR39","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1128\/JCM.02529-09","volume":"48","author":"AF Shorr","year":"2010","unstructured":"Shorr AF, Haque N, Taneja C, et al. Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia. J Clin Microbiol. 2010;48(9):3258\u201362.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"254_CR40","doi-asserted-by":"crossref","first-page":"E142","DOI":"10.1111\/1469-0691.12022","volume":"19","author":"N Sicot","year":"2013","unstructured":"Sicot N, Khanafer N, Meyssonnier V, et al. Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia\u2013results of a prospective observational study. Clin Microbiol Infect. 2013;19(3):E142\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"254_CR41","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"6","key":"254_CR42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa1800201","volume":"380","author":"R Stets","year":"2019","unstructured":"Stets R, Popescu M, Gonong JR, et al. Omadacycline for community-acquired bacterial pneumonia. N Engl J Med. 2019;380(6):517\u201327.","journal-title":"N Engl J Med"},{"issue":"3","key":"254_CR43","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MCP.0b013e3283292666","volume":"15","author":"E Tacconelli","year":"2009","unstructured":"Tacconelli E, De Angelis G. Pneumonia due to methicillin-resistant Staphylococcus aureus: clinical features, diagnosis and management. Curr Opin Pulm Med. 2009;15(3):218\u201322.","journal-title":"Curr Opin Pulm Med"},{"issue":"9","key":"254_CR44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075171","volume":"8","author":"M Tadros","year":"2013","unstructured":"Tadros M, Williams V, Coleman BL, et al. Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals. PLoS ONE. 2013;8(9): e75171.","journal-title":"PLoS ONE"},{"issue":"2","key":"254_CR45","first-page":"247","volume":"84","author":"N Thabet","year":"2022","unstructured":"Thabet N, Shindo Y, Okumura J, et al. Clinical characteristics and risk factors for mortality in patients with community-acquired staphylococcal pneumonia. Nagoya J Med Sci. 2022;84(2):247\u201359.","journal-title":"Nagoya J Med Sci"},{"issue":"7","key":"254_CR46","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1007\/s00284-021-02512-x","volume":"78","author":"L Tilouche","year":"2021","unstructured":"Tilouche L, Ben DR, Boughattas S, et al. Staphylococcus aureus ventilator-associated pneumonia: a study of bacterio-epidemiological profile and virulence factors. Curr Microbiol. 2021;78(7):2556\u201362.","journal-title":"Curr Microbiol"},{"issue":"2","key":"254_CR47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/arm91020012","volume":"91","author":"KQ Tran","year":"2023","unstructured":"Tran KQ, Nguyen TTD, Pham VH, et al. Pathogenic role and antibiotic resistance of methicillin-resistant Staphylococcus aureus (MRSA) strains causing severe community-acquired pneumonia in Vietnamese children. Adv Respir Med. 2023;91(2):135\u201345.","journal-title":"Adv Respir Med"},{"issue":"6","key":"254_CR48","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","volume":"54","author":"SJ van Hal","year":"2012","unstructured":"van Hal SJ, Lodise TP, Paterson DL. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis. 2012;54(6):755\u201371.","journal-title":"Clin Infect Dis"},{"key":"254_CR49","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.GPP3-0057-2018","author":"M Vestergaard","year":"2019","unstructured":"Vestergaard M, Frees D, Ingmer H. Antibiotic resistance and the MRSA problem. Microbiol Spectr. 2019. https:\/\/doi.org\/10.1128\/microbiolspec.GPP3-0057-2018.","journal-title":"Microbiol Spectr"},{"issue":"11","key":"254_CR50","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/toxins12110721","volume":"12","author":"J Vlaeminck","year":"2020","unstructured":"Vlaeminck J, Raafat D, Surmann K, et al. Exploring virulence factors and alternative therapies against Staphylococcus aureus pneumonia. Toxins (Basel). 2020;12(11):721.","journal-title":"Toxins (Basel)"},{"issue":"5","key":"254_CR51","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1586\/17476348.2014.940323","volume":"8","author":"C Woods","year":"2014","unstructured":"Woods C, Colice G. Methicillin-resistant Staphylococcus aureus pneumonia in adults. Expert Rev Respir Med. 2014;8(5):641\u201351.","journal-title":"Expert Rev Respir Med"},{"issue":"12","key":"254_CR52","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/CM9.0000000000000270","volume":"132","author":"QR Zhang","year":"2019","unstructured":"Zhang QR, Chen H, Liu B, et al. Methicillin-resistant Staphylococcus aureus pneumonia in diabetics: a single-center, retrospective analysis. Chin Med J (Engl). 2019;132(12):1429\u201334.","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"254_CR53","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1469-0691.2007.01947.x","volume":"14","author":"O Dumitrescu","year":"2008","unstructured":"Dumitrescu O, Badiou C, Bes M, et al. Effect of antibiotics, alone and in combination, on panton-valentine leukocidin production by a Staphylococcus aureus reference strain. Clin Microbiol Infect. 2008;14(4):384\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"254_CR54","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1128\/AAC.01201-06","volume":"51","author":"O Dumitrescu","year":"2007","unstructured":"Dumitrescu O, Boisset S, Badiou C, et al. Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin. Antimicrob Agents Chemother. 2007;51(4):1515\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"254_CR55","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1186\/cc11447","volume":"16","author":"C Marti","year":"2012","unstructured":"Marti C, Garin N, Grosgurin O, et al. Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis. Crit Care. 2012;16(4):R141.","journal-title":"Crit Care"}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-024-00254-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-024-00254-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-024-00254-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T15:03:08Z","timestamp":1722006188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-024-00254-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["254"],"URL":"https:\/\/doi.org\/10.1007\/s41030-024-00254-2","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"value":"2364-1754","type":"print"},{"value":"2364-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"assertion":[{"value":"10 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Thu Vo-Pham-Minh, Dang Tran-Cong, Thien Dinh-Chi; Hung Phan-Viet; Tran Nguyen-Thi-Hong; Thuy Cao-Thi-My; Hien Nguyen-Thi-Dieu; Vu Nguyen-Thien, and Duong Vo-Thai, Sy Duong-Quy declared that they have no conflict of interests. Sy Duong-Quy is an Editorial Board member of <i>Pulmonary Therapy<\/i> and was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in this study were approved by the Institutional Review Board of Can Tho University of Medicine and Pharmacy (IRB approval number 1388\/QD-DHYDCT, June 2021) and were conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. Participants were informed of the study\u2019s purpose and their right to withdraw at any time. There are no interventions were performed on the participants in this observational study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}